 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 12/02/2019 |
$87.84 |
$88.03 |
$87.00 |
$87.03 |
6.53M | | 12/03/2019 |
$85.96 |
$86.48 |
$85.59 |
$85.95 |
10.05M | | 12/04/2019 |
$86.18 |
$87.55 |
$86.12 |
$87.20 |
6.17M | | 12/05/2019 |
$87.25 |
$87.25 |
$86.26 |
$86.72 |
6.07M | | 12/06/2019 |
$87.21 |
$87.71 |
$86.78 |
$86.98 |
6.04M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. |
|
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on December 02, 2019, ABBV opened at $87.84, traded as high as $88.03 and as low as $87.00, and closed at $87.03. Trading volume was a total of 6.53M shares. On December 03, 2019, ABBV opened at $85.96, traded as high as $86.48 and as low as $85.59, and closed at $85.95. Trading volume was a total of 10.05M shares. On December 04, 2019, ABBV opened at $86.18, traded as high as $87.55 and as low as $86.12, and closed at $87.20. Trading volume was a total of 6.17M shares. On December 05, 2019, ABBV opened at $87.25, traded as high as $87.25 and as low as $86.26, and closed at $86.72. Trading volume was a total of 6.07M shares. On December 06, 2019, ABBV opened at $87.21, traded as high as $87.71 and as low as $86.78, and closed at $86.98. Trading volume was a total of 6.04M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
12/06/2019 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$86.98 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
373.70 |
|
| Dividends reinvested/share: |
$17.99 |
|
| Total return: |
225.04% |
|
| Average Annual Total Return: |
18.55% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$32,512.22 |
|
| Years: |
6.93 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
12/06/2019 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$86.98 |
|
| Dividends collected/share: |
$17.99 |
|
| Total return: |
198.89% |
|
| Average Annual Total Return: |
17.12% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$29,890.19 |
|
| Years: |
6.93 |
|
|
|
| Date |
Close |
| 12/02/2019 | $87.03 | | 12/03/2019 | $85.95 | | 12/04/2019 | $87.20 | | 12/05/2019 | $86.72 | | 12/06/2019 | $86.98 |
|
|
